Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Article
Dans Anglais
| IMSEAR
| ID: sea-45576
ABSTRACT
BACKGROUND:
Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies.OBJECTIVE:
Using recombinant activated factor VII in primary postpartum hemorrhage. MATERIAL ANDMETHOD:
Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed.RESULTS:
The intractable hemorrhage stopped after treatment with recombinant activated factor VIICONCLUSION:
The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Protéines recombinantes
/
Femelle
/
Humains
/
Grossesse
/
Facteur VIIa
/
Résultat thérapeutique
/
Échec thérapeutique
/
Adulte
/
Hémorragie de la délivrance
langue:
Anglais
Année:
2007
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS